Globus Medical Q1 2022 Earnings Report
Key Takeaways
Globus Medical reported a 1.4% increase in worldwide net sales, reaching $230.5 million. GAAP net income decreased by 16.0% to $38.1 million, with diluted EPS at $0.37 and non-GAAP diluted EPS at $0.42. The company reaffirmed its full-year 2022 guidance of $1.025 billion in net sales and non-GAAP diluted earnings per share of $2.10.
Worldwide net sales increased by 1.4% to $230.5 million compared to Q1 2021.
GAAP net income decreased to $38.1 million, a 16.0% drop from the previous year.
GAAP diluted EPS was $0.37, while non-GAAP diluted EPS was $0.42.
The company reaffirmed its full-year 2022 guidance with sales target of $1.025 billion and non-GAAP diluted EPS of $2.10.
Globus Medical
Globus Medical
Globus Medical Revenue by Segment
Globus Medical Revenue by Geographic Location
Forward Guidance
The Company today reaffirmed its full year 2022 guidance of $1.025 billion in net sales and non-GAAP diluted earnings per share of $2.10.
Revenue & Expenses
Visualization of income flow from segment revenue to net income